Immunotherapy as sensitizer for local radiotherapy-Reference-Cited by-同舟云学术

Immunotherapy as sensitizer for local radiotherapy

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Vanneste Ben G.L.¹^ORCID,Van Limbergen Evert J¹,Dubois Ludwig²^ORCID,Samarska Iryna V.³,Wieten L.⁴,Aarts M. J.B.⁵,Marcelissen T.⁶,De Ruysscher Dirk¹

Affiliation:

1. Department of Radiation Oncology (MAASTRO Clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands

2. The M-Lab, Department of Precision Medicine, GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands

3. Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands

4. Department of Transplantation Immunology, Tissue Typing Laboratory, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands

5. Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands

6. Department of Urology, Maastricht University Medical Center, Maastricht, The Netherlands

Funder

Varian

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1832760

Reference70 articles.

1. Chemoradiotherapy of Locally Advanced Esophageal Cancer

2. Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410